Boundless Bio Inc.

Last updated September 27, 2026

Organization details

Legal name
Boundless Bio Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
La Jolla
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BOLD
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001782303
EIN
83-0751369
Wikidata ID
Q104481180

Board of directors

Chief executives

Zachary Hornby · President & CEO
Since March 2024

Director election results

Annual meeting of June 15, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 8 other boards. 8 are in the same sector.

Network of Boundless Bio Inc.'s board connections Beam Therapeutics Inc. Beam Therapeutics Inc. Caribou Biosciences Inc. Caribou Biosciences In... Erasca Inc. Erasca Inc. Gossamer Bio Inc. Gossamer Bio Inc. Kardigan Inc. Kardigan Inc. Maze Therapeutics Inc. Maze Therapeutics Inc. Neumora Therapeutics Inc. Neumora Therapeutics I... Scholar Rock Holding Corporation Scholar Rock Holding C... Jonathan E. Lim Jonathan E. Lim Kristina Burow Kristina Burow Nancy Whiting Nancy Whiting Boundless Bio Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$1,973,470
35 purchases by 1 insider
Sold, last 12 months
$134,031
3 sales by 3 insiders
Date Insider Transaction Shares Price Value
Nov 10, 2026 Kevin Tang 10% owner Open-market purchase +249 $2.40 $598
Nov 6, 2026 Kevin Tang 10% owner Open-market purchase +1,700 $2.40 $4,080
Nov 5, 2026 Kevin Tang 10% owner Open-market purchase +8,390 $2.40 $20,136
Nov 4, 2026 Kevin Tang 10% owner Open-market purchase +517 $2.40 $1,241
Nov 3, 2026 Kevin Tang 10% owner Open-market purchase +2,255 $2.40 $5,412
Oct 27, 2026 Kevin Tang 10% owner Open-market purchase +10,707 $2.40 $25,697
Oct 26, 2026 Kevin Tang 10% owner Open-market purchase +9,606 $2.38 $22,862
Oct 23, 2026 Kevin Tang 10% owner Open-market purchase +6,234 $2.38 $14,837
Oct 22, 2026 Kevin Tang 10% owner Open-market purchase +5,800 $2.40 $13,920
Oct 20, 2026 Kevin Tang 10% owner Open-market purchase +220 $2.37 $521
Oct 19, 2026 Kevin Tang 10% owner Open-market purchase +12,790 $2.34 $29,929
Oct 19, 2026 Kevin Tang 10% owner Open-market purchase +18,279 $2.33 $42,590
Oct 16, 2026 Kevin Tang 10% owner Open-market purchase +118,185 $2.34 $276,553
Aug 26, 2026 TANG CAPITAL MANAGEMENT LLC 10% owner Open-market sale −18,300 $2.97 $54,351
Jul 21, 2026 Kevin Tang 10% owner Open-market purchase +2,975 $2.44 $7,259

Organizations in the same sector, closest in location and size first.

Questions about Boundless Bio Inc.

Who is the CEO of Boundless Bio Inc.?

Zachary Hornby has been Boundless Bio Inc.'s President & CEO since March 2024.

How many directors are on Boundless Bio Inc.'s board?

Boundless Bio Inc.'s board has 7 directors: Christine Brennan, James Christensen, Jennifer Lew, Jonathan E. Lim, Kristina Burow, Nancy Whiting and Zachary Hornby.

Are Boundless Bio Inc. insiders buying or selling shares?

Over the last 12 months, Boundless Bio Inc. insiders bought $2.0 million of shares in 35 purchases and sold $134,031 of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="boundless-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.